Two genetically-modified broadly-neutralizing antibodies have been demonstrated to elicit long-term protection against an HIV-like virus in rhesus macaques, with a Phase I clinical trial now underway.
Take a look at how advancements in genetic engineering has led to advances in vaccine manufacturing, with a divergence from live cell cultures to recombinant production in host cells.
A new study has identified a common pattern of immune response in Ebola-infected monkeys 4 days prior to the development of fever; this response could be utilized as an early diagnosis biomarker.
In this interview, we speak to Dr. Bryan Kraft, an Assistant Professor of Medicine at Duke University, about his research into carbon monoxide as a potential therapy to treat ARDS and the clinical trial for this therapy that is currently underway.
A small clinical trial has demonstrated that an IL-7 drug that revs up the body’s immune system holds promise in sepsis patients, potentially offering a new approach to improve survival rates.
A new test could extend the window for accurately detecting Zika virus, presenting a fast, cheap alternative.
In this interview, take a look behind the scenes of a recent Future Microbiology review on influenza virus infection in pregnancy with author, Lucy Somerville.
Listen to the top stories in infectious diseases this week, including novel CRISPR-based diagnostics, clinical trial in tuberculosis and the latest CDC approvals for the flu vaccine.
A new study has revealed that serum IgA antibodies deliver a protective barrier against polymicrobial sepsis in mice, providing us with a further understanding of its role in host protection.
In our latest infographic we provide a visual snapshot of the infections and immune processes that have been linked with the microbiome thus far, explaining some of the evidence
